327 related articles for article (PubMed ID: 16152779)
1. [Patients suffering dilated chagasic cardiopathy or non chagasic cardiopathy show an increased levels of tumor necrosis factor alpha].
D'Angelo-Mendoza E; Rodríguez-Bonfante C; Camacho I; Martínez J; Perdomo T; Cabrera A; Bonfante-Cabarcas R
Invest Clin; 2005 Sep; 46(3):229-40. PubMed ID: 16152779
[TBL] [Abstract][Full Text] [Related]
2. The influence of aetiology on inflammatory and neurohumoral activation in patients with severe heart failure: a prospective study comparing Chagas' heart disease and idiopathic dilated cardiomyopathy.
Mocelin AO; Issa VS; Bacal F; Guimarães GV; Cunha E; Bocchi EA
Eur J Heart Fail; 2005 Aug; 7(5):869-73. PubMed ID: 16043406
[TBL] [Abstract][Full Text] [Related]
3. [Chagasic myocardiopathy: historical perspective].
Elizari MV
Medicina (B Aires); 1999; 59 Suppl 2():25-40. PubMed ID: 10668240
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor-alpha promoter polymorphism in Mexican patients with Chagas' disease.
Rodríguez-Pérez JM; Cruz-Robles D; Hernández-Pacheco G; Pérez-Hernández N; Murguía LE; Granados J; Reyes PA; Vargas-Alarcón G
Immunol Lett; 2005 Apr; 98(1):97-102. PubMed ID: 15790514
[TBL] [Abstract][Full Text] [Related]
5. Maximal functional capacity in patients with Chagas' cardiomyopathy without congestive heart failure.
Mady C; Ianni BM; Arteaga E; Salemi VM; de Carvalho Frimm C
J Card Fail; 2000 Sep; 6(3):220-4. PubMed ID: 10997748
[TBL] [Abstract][Full Text] [Related]
6. [Left ventricular mechanics in Chagas' disease and primary dilated myocardiopathies. A hemodynamic study].
Gómez de Pereira C; Carrasco HA; Guerrero L; Parada H; Molina C; Chuecos R
Arch Inst Cardiol Mex; 1991; 61(5):435-40. PubMed ID: 1772315
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of histologic changes in Chagas' cardiomyopathy and dilated cardiomyopathy].
Barretto AC; Higuchi ML; da Luz PL; Lopes EA; Bellotti G; Mady C; Stolf N; Arteaga-Fernández E; Pileggi F
Arq Bras Cardiol; 1989 Feb; 52(2):79-83. PubMed ID: 2596992
[TBL] [Abstract][Full Text] [Related]
8. [C-reactive protein and interleukin-6 serum levels increase as Chagas disease progresses towards cardiac failure].
López L; Arai K; Giménez E; Jiménez M; Pascuzo C; Rodríguez-Bonfante C; Bonfante-Cabarcas R
Rev Esp Cardiol; 2006 Jan; 59(1):50-6. PubMed ID: 16434004
[TBL] [Abstract][Full Text] [Related]
9. [Magnetic resonance imaging in chronic Chagas cardiopathy. Correlation with endomyocardial biopsy findings].
Kalil R; Bocchi EA; Ferreira BM; de Lourdes Higuchi M; Lopes NH; Magalhães AC; Mady C; Pereira Barretto AC; Albuquerque CP; Bellotti G
Arq Bras Cardiol; 1995 Nov; 65(5):413-6. PubMed ID: 8729858
[TBL] [Abstract][Full Text] [Related]
10. IgG subclass reactivity to Trypanosoma cruzi in chronic chagasic patients.
Hernández-Becerril N; Nava A; Reyes PA; Monteón VM
Arch Cardiol Mex; 2001; 71(3):199-205. PubMed ID: 11665655
[TBL] [Abstract][Full Text] [Related]
11. Presence of antiheart and antiskeletal muscle glycolipid autoantibodies in the sera of patients with chagasic cardiopathy.
Laguens RP; Argel MI; Chambó J; Storino R; Cabeza Meckert PM
Can J Cardiol; 1994 Sep; 10(7):769-76. PubMed ID: 7922834
[TBL] [Abstract][Full Text] [Related]
12. Norepinephrine and heart rate variability: a marker of dysautonomia in chronic Chagas cardiopathy.
Cunha AB; Cunha DM; Pedrosa RC; Flammini F; Silva AJ; Saad EA; Kopiler DA
Rev Port Cardiol; 2003 Jan; 22(1):29-52. PubMed ID: 12712809
[TBL] [Abstract][Full Text] [Related]
13. Right ventricular dysfunction is an independent predictor of survival in patients with dilated chronic Chagas' cardiomyopathy.
Nunes Mdo C; Rocha MO; Ribeiro AL; Colosimo EA; Rezende RA; Carmo GA; Barbosa MM
Int J Cardiol; 2008 Jul; 127(3):372-9. PubMed ID: 17689706
[TBL] [Abstract][Full Text] [Related]
14. Elevated concentrations of CCL2 and tumor necrosis factor-alpha in chagasic cardiomyopathy.
Talvani A; Rocha MO; Barcelos LS; Gomes YM; Ribeiro AL; Teixeira MM
Clin Infect Dis; 2004 Apr; 38(7):943-50. PubMed ID: 15034825
[TBL] [Abstract][Full Text] [Related]
15. [Specific dilated myocardiopathy. Chronic chagasic cardiopathy at the National Institute of Cardiology Ignacio Chávez].
Monteón-Padilla VM; Vargas-Alarcón G; Vallejo-Allende M; Reyes PA
Arch Cardiol Mex; 2002; 72 Suppl 1():S148-52. PubMed ID: 12001835
[TBL] [Abstract][Full Text] [Related]
16. [Behavior of the ST segment, during isometric exercise, in chagasic patients with apical aneurysm of the left ventricle].
Torres A; Donis JH; Navas M; Fuenmayor AJ; Gottberg C; Dávila DF
Arch Inst Cardiol Mex; 1989; 59(5):499-504. PubMed ID: 2604492
[TBL] [Abstract][Full Text] [Related]
17. Antioxidant therapy attenuates oxidative stress in chronic cardiopathy associated with Chagas' disease.
Maçao LB; Wilhelm Filho D; Pedrosa RC; Pereira A; Backes P; Torres MA; Fröde TS
Int J Cardiol; 2007 Dec; 123(1):43-9. PubMed ID: 17328977
[TBL] [Abstract][Full Text] [Related]
18. Endothelial function is preserved in Chagas' heart disease patients without heart failure.
Consolim-Colombo FM; Lopes HF; Rosetto EA; Rubira MC; Barreto-Filho JA; Baruzzi AC; Rocha NN; Mady C; Irigoyen MC; Krieger EM
Endothelium; 2004; 11(5-6):241-6. PubMed ID: 15763943
[TBL] [Abstract][Full Text] [Related]
19. The relationship between heart rate variability and serum cytokines in chronic chagasic patients with persistent parasitemia.
Llaguno M; Pertili LA; da Silva MV; Bunazar P; Reges AM; Faleiros AC; Lages-Silva E; Rodrigues Junior V; da Silva VJ; Correia Filho D
Pacing Clin Electrophysiol; 2011 Jun; 34(6):724-35. PubMed ID: 21276024
[TBL] [Abstract][Full Text] [Related]
20. [Relationship between ventricular arrhythmia and cardiac function in Chagas disease].
Barretto AC; Mady C; Ianni BM; Arteaga E; Cardoso RH; da Luz PL; Pileggi F
Arq Bras Cardiol; 1995 Jun; 64(6):533-5. PubMed ID: 8561672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
